OGEN · Oragenics Inc. Common Stock
View on chartInsiders & Stakes
| Fred Telling Director | ▼ Sell | Open Market | 34,538 Shares held | 12/12/2025 | View profile |
| Sullivan Michael O'Keefe Interim PEO, CFO | ▲ Buy | Open Market | 34,255 Shares held | 3/29/2022 | View profile |
| Alan W. Dunton Director | ▼ Sell | Open Market | 25,623 Shares held | 12/6/2024 | View profile |
| Charles L. Pope Director | ▲ Buy | Grant | 25,471 Shares held | 8/8/2023 | View profile |
| Kimberly M. Murphy CEO and President | ▲ Buy | Grant | 25,000 Shares held | 8/8/2023 | View profile |
| Robert C. Koski Director | ▼ Sell | Other | 23,367 Shares held | 12/11/2024 | View profile |
| Janet Huffman CFO, PAO, PFO | ▲ Buy | Grant | 15,000 Shares held | 8/8/2023 | View profile |
| Odyssey Health, Inc. 10% Owner | ▼ Sell | Open Market | 0 Shares held | 6/18/2025 | View profile |
Transaction History
| Fred Telling | ▼ Sell | Open Market | 210 | $198 | 12/12/2025 |
| Odyssey Health, Inc. | ▼ Sell | Open Market | 5,044 | $21K | 6/18/2025 |
| Odyssey Health, Inc. | ▼ Sell | Open Market | 2,000 | $9K | 6/17/2025 |
| Odyssey Health, Inc. | ▼ Sell | Open Market | 5,000 | $22K | 6/16/2025 |
| Odyssey Health, Inc. | ▼ Sell | Open Market | 5,000 | $21K | 6/13/2025 |
| Robert C. Koski | ▼ Sell | Other | 5,000 | — | 12/11/2024 |
| Alan W. Dunton | ▼ Sell | Open Market | 66 | $24 | 12/6/2024 |
| Fred Telling | ▼ Sell | Open Market | 3,597 | $1K | 12/6/2024 |
| Fred Telling | ▼ Sell | Open Market | 3,500 | $12K | 11/30/2023 |
| Janet Huffman | ▲ Buy | Grant | 15,000 | $0 | 8/8/2023 |
| Robert C. Koski | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 |
| Charles L. Pope | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 |
| Kimberly M. Murphy | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 |
| Alan W. Dunton | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 |
| Fred Telling | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 |
| Robert C. Koski | ▼ Sell | Open Market | 42,357 | $4K | 12/30/2022 |
| Robert C. Koski | ▼ Sell | Open Market | 36,648 | $4K | 12/29/2022 |
| Robert C. Koski | ▼ Sell | Open Market | 140,497 | $25K | 12/15/2022 |
| Robert C. Koski | ▼ Sell | Open Market | 25,000 | $4K | 12/14/2022 |
| Robert C. Koski | ▼ Sell | Open Market | 4,503 | $788 | 12/14/2022 |
| Robert C. Koski | ▼ Sell | Open Market | 48,795 | $10K | 12/9/2022 |
| Robert C. Koski | ▼ Sell | Open Market | 13,036 | $3K | 12/8/2022 |
| Robert C. Koski | ▼ Sell | Open Market | 200,000 | $38K | 11/30/2022 |
| Robert C. Koski | ▼ Sell | Open Market | 200,000 | $38K | 11/29/2022 |
| Fred Telling | ▲ Buy | Open Market | 10,084 | $3K | 6/17/2022 |
| Fred Telling | ▲ Buy | Open Market | 78,673 | $23K | 5/24/2022 |
| Fred Telling | ▲ Buy | Open Market | 3,500 | $1K | 5/23/2022 |
| Fred Telling | ▲ Buy | Open Market | 65,718 | $19K | 5/20/2022 |
| Fred Telling | ▲ Buy | Open Market | 56,806 | $16K | 5/19/2022 |
| Fred Telling | ▲ Buy | Open Market | 15,303 | $4K | 5/18/2022 |
| Fred Telling | ▲ Buy | Open Market | 59,053 | $21K | 3/31/2022 |
| Fred Telling | ▲ Buy | Open Market | 124,785 | $45K | 3/30/2022 |
| Sullivan Michael O'Keefe | ▲ Buy | Open Market | 20,000 | $7K | 3/29/2022 |
| Robert C. Koski | ▲ Buy | Open Market | 799,100 | $379K | 12/31/2021 |
| Robert C. Koski | ▲ Buy | Open Market | 200,900 | $90K | 12/30/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Oragenics (OGEN) noted in after‑market health‑care stock activity
OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.
Oragenics (OGEN) noted in after‑market health‑care stock activity. OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.